pubmed-article:19487835 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0011065 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0014518 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0038325 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C1704456 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C1549464 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:19487835 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
pubmed-article:19487835 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19487835 | pubmed:dateCreated | 2009-6-2 | lld:pubmed |
pubmed-article:19487835 | pubmed:abstractText | Systemic administration of corticosteroid, plasmapheresis and high-dose immunoglobulin therapy (IVIG) are the main treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). | lld:pubmed |
pubmed-article:19487835 | pubmed:language | jpn | lld:pubmed |
pubmed-article:19487835 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487835 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19487835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487835 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19487835 | pubmed:month | May | lld:pubmed |
pubmed-article:19487835 | pubmed:issn | 0021-4884 | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:AiharaMichiko... | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:IkezawaZenroZ | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:YamakawaYukoY | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:MatsukuraSets... | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:TatewakiSatok... | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:KanbaraTakesh... | lld:pubmed |
pubmed-article:19487835 | pubmed:author | pubmed-author:YamaneYumikoY | lld:pubmed |
pubmed-article:19487835 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19487835 | pubmed:volume | 58 | lld:pubmed |
pubmed-article:19487835 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19487835 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19487835 | pubmed:pagination | 537-47 | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:meshHeading | pubmed-meshheading:19487835... | lld:pubmed |
pubmed-article:19487835 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19487835 | pubmed:articleTitle | [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]. | lld:pubmed |
pubmed-article:19487835 | pubmed:affiliation | Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Japan. yumiko@dream.design.co.jp | lld:pubmed |
pubmed-article:19487835 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19487835 | pubmed:publicationType | English Abstract | lld:pubmed |